4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000061
EVP, Chief Business Officer sold 375 shares at $39.79 ($14,920)
- EVP, Chief Business Officer acquired 904 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Baroldi Joseph · EVP, Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-17 | Exercise or conversion : show line 1 in the form | +904 | 1,226 | I | ||
| 2023-01-18 | Sale : show line 2 in the form | −375 | $39.79 | $14,920 | 851 | I |
| Open-market sales · 375 sh · avg $39.79 · $14,920 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-17 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −904 | $0.00 | 904 | 3,962 | I |
Loading xslF345X03/edgardoc.xml…